 |
acalabrutinib |
|---|---|
| Trade Name | Calquence |
| Orphan Indication | Mantle cell lymphoma |
| USA Market Approval | USA |
| USA Designation Date | 2015-09-21 00:00:00 |
| Sponsor | Acerta Pharma BV;Molenstraat 110, 5342 CC Oss; |
| |
acalabrutinib |
|---|---|
| Trade Name | Calquence |
| Orphan Indication | Mantle cell lymphoma |
| USA Market Approval | USA |
| USA Designation Date | 2015-09-21 00:00:00 |
| Sponsor | Acerta Pharma BV;Molenstraat 110, 5342 CC Oss; |